Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Sarepta Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:SRPT | Benzinga

Q: What sector and industry does Sarepta Therapeutics (SRPT) operate in?

Sarepta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Sarepta Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SRPT.

Open	$63.50
Close	$63.51
Volume / Avg.	1.40M / 1.95M
Day Range	$63.02 - $64.30
52 Wk Range	48.01 - 173.25
Market Cap	$6.30B
P/E Ratio	26.83
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	7.9%
Days to Cover	1.9

Recent News

Netflix To Rally More Than 55%? Here Are 10 Top Analyst Forecasts For Monday

Avi Kapoor

Can Solid Biosciences Challenge Sarepta in the DMD Market?

When it comes to treating Duchenne muscular dystrophy (DMD), big news recently surfaced. DMD is a muscle disease. It usually first shows up in boys aged two to five years. Genetic alterations cause it, and the condition

MarketBeat

Sarepta/Roche Suspend Elevidys Gene Therapy Trials In Europe After Patient Death

Sarepta and Roche paused Elevidys trials in the EU after a patient death. Analysts warn of potential sales declines as safety concerns impact market outlook.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$63.50
Close	$63.51
Volume / Avg.	1.40M / 1.95M
Day Range	$63.02 - $64.30
52 Wk Range	48.01 - 173.25
Market Cap	$6.30B
P/E Ratio	26.83
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	7.9%
Days to Cover	1.9

About Sarepta Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other ...

Got Questions? Ask

What is SRPT's 7 days volume trend?

What is SRPT's all-time high price?

What is SRPT's gross margin?

What is the consensus rating for SRPT?

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Sarepta Therapeutics (SRPT) stock?

You can purchase shares of Sarepta Therapeutics (NASDAQ:SRPT) through any online brokerage.

View our list of the best stock brokerages

Who are Sarepta Therapeutics (SRPT) competitors?

Other companies in Sarepta Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Ionis Pharmaceuticals (NASDAQ:IONS).

What is the forecast, or price target, for Sarepta Therapeutics (SRPT) stock?

Sarepta Therapeutics has a consensus price target of $155.27.

What is the current price for Sarepta Therapeutics (SRPT)?

The stock price for Sarepta Therapeutics (NASDAQ: SRPT) is $64.1061 last updated May 2, 2025 at 7:58 PM EDT.

Does Sarepta Therapeutics (SRPT) pay a dividend?

There are no upcoming dividends for Sarepta Therapeutics.

When is Sarepta Therapeutics (NASDAQ:SRPT) reporting earnings?

Sarepta Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.

Is Sarepta Therapeutics (SRPT) going to split?

There is no upcoming split for Sarepta Therapeutics.

What sector and industry does Sarepta Therapeutics (SRPT) operate in?

Sarepta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Sarepta Therapeutics Stock Price, Quotes and Forecasts

Sarepta Therapeutics (SRPT) Forecast